Trabectedin Patent Expiration
Trabectedin was first introduced by Janssen Products Lp
Trabectedin Patents
Given below is the list of patents protecting Trabectedin, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Yondelis |
US8895557 (Pediatric) | Pharmaceutical formulations of ecteinascidin compounds | Jul 07, 2028 | Janssen Prods |
Yondelis | US8895557 | Pharmaceutical formulations of ecteinascidin compounds | Jan 07, 2028 | Janssen Prods |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Trabectedin's patents.
Latest Legal Activities on Trabectedin's Patents
Given below is the list recent legal activities going on the following patents of Trabectedin.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 8th Year, Large Entity | 25 May, 2022 | US8895557 |
Change in Power of Attorney (May Include Associate POA) Critical | 01 Jul, 2020 | US8895557 |
Email Notification Critical | 01 Jul, 2020 | US8895557 |
Correspondence Address Change Critical | 29 Jun, 2020 | US8895557 |
Email Notification Critical | 18 Jun, 2020 | US8895557 |
Change in Power of Attorney (May Include Associate POA) Critical | 18 Jun, 2020 | US8895557 |
Payment of Maintenance Fee, 4th Year, Large Entity | 25 May, 2018 | US8895557 |
Patent Issue Date Used in PTA Calculation Critical | 25 Nov, 2014 | US8895557 |
Recordation of Patent Grant Mailed Critical | 25 Nov, 2014 | US8895557 |
Email Notification Critical | 06 Nov, 2014 | US8895557 |